Valeant Pharmaceuticals reported $23.17B in Loan Capital for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Amgen AMGN:US $ 35705M 305M
Aurora Cannabis Inc ACB:CN 343.55M 26.3M
Biogen BIIB:US $ 6277.4M 1.7M
Bristol Myers Squibb BMY:US $ 37107M 343M
Canopy Growth Corp WEED:CN C$ 1.26B 270.14M
Catalent CTLT:US $ 4157M 34M
Corcept Therapeutics CORT:US $ 0M 0M
Danaher DHR:US $ 20052M 1716M
Eli Lilly And LLY:US $ 14692M 460.9M
Horizon Pharma HZNP:US $ 2550.99M 1.75M
JAZZ PHA JAZZ:US $ 5990M 2.87M
Lannett LCI:US $ 610.08M 6.6M
Nektar Therapeutics NKTR:US $ 0M 0M
Pacira Pharmaceuticals PCRX:US $ 721.88M 7.86M
Perrigo Ordinary Shares PRGO:US $ 4086.1M 575.5M
Phibro Animal Health PAHC:US $ 400.62M 13.3M
Prestige Brands PBH:US $ 1476.23M 4.93M
Revance Therapeutics RVNC:US $ 378.38M 52.48M
Supernus Pharmaceuticals SUPN:US $ 0M 400.38M
Valeant Pharmaceuticals VRX:CN $ 23168M 514M
Vertex Pharmaceuticals VRTX:US $ 482.3M 13.2M
Zoetis ZTS:US $ 5221M 7M